‘‘(B) COMPOSITION.—Each member of the 
Commission shall be appointed to represent one 
of the following four categories: 
‘‘(i) The varied disciplines within the 
health information technology field. 
‘‘(ii) The varied disciplines within the 
medical field that are not described in 
clause (i). 
‘‘(iii) Individuals who— 
‘‘(I) represent a patient-led, pa-
tient-centered organization with a pa-
tient constituency; 
‘‘(II) have experience with health 
information technology and privacy; 
and 
‘‘(III) are trained, knowledgeable, 
and prepared to participate in the de-
cisionmaking process regarding health 
information technology. 
‘‘(iv) Officers or employees of the 
Federal Government. 
‘‘(C) REPRESENTATION
OF
MEMBERSHIP 
CATEGORIES.—At least two members of the 
Commission shall represent each of the cat-
egories described in subparagraph (B). 
VerDate Mar 15 2010 
02:37 Dec 04, 2012
Jkt 029200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H6626.IH
H6626
pwalker on DSK7TPTVN1PROD with
‘‘(D) TRAVEL EXPENSES.—Each member 
shall receive travel expenses, including per diem 
in lieu of subsistence, in accordance with appli-
cable provisions under subchapter I of chapter 
57 of title 5, United States Code. 
‘‘(E) FIRST
MEETING.—The Commission 
shall hold its first meeting not later than 180 
days after the date of the enactment of this 
Act. 
‘‘(4) REPORT
TO
THE
NATIONAL
COORDI-
NATOR.—Not later than one year after the date of 
enactment of this Act, the Commission shall submit 
to the National Coordinator a report containing the 
areas, benchmarks, and restrictions on the uses of 
prize awards that the Commission identifies for the 
prize program under paragraph (2). 
‘‘(5) TERMINATION.—The Commission shall 
terminate upon submitting its report to the National 
Coordinator under paragraph (4). 
‘‘(f) AUTHORIZATION OF APPROPRIATIONS.—In addi-
tion to sums authorized to be appropriated to carry out 
this subtitle under section 3020, there is authorized to be 
appropriated to carry out this section $33,000,000 for fis-
cal year 2014.’’. 
(b) CONFORMING AMENDMENTS.— 
VerDate Mar 15 2010 
02:37 Dec 04, 2012
Jkt 029200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H6626.IH
H6626
pwalker on DSK7TPTVN1PROD with
(1) Section 3011 of such Act (42 U.S.C. 300jj- 
31) is amended— 
(A) in subsection (a), by striking ‘‘section 
3018’’ and inserting ‘‘section 3020’’; and 
(B) in subsection (b), by striking ‘‘section 
3018’’ and inserting ‘‘section 3020’’. 
(2) Section 3020 of such Act (as so redesig-
nated) is amended by inserting ‘‘except for section 
3018,’’ after ‘‘For purposes of carrying out this sub-
title,’’. 
SEC. 5. ESTABLISHMENT OF THE OFFICE OF WIRELESS 
HEALTH TECHNOLOGY. 
Chapter X of the Federal Food, Drug, and Cosmetic 
Act (21 U.S.C. 391 et seq.) is amended by adding at the 
end the following new section: 
‘‘SEC. 1013. OFFICE OF WIRELESS HEALTH TECHNOLOGY. 
‘‘(a) ESTABLISHMENT.—There is established within 
the Office of the Commissioner an office to be known as 
the Office of Wireless Health Technology (referred to in 
this section as the ‘Office’), which shall be headed by a 
director. 
‘‘(b) APPOINTMENT OF FIRST DIRECTOR.—The first 
Director of the Office shall be appointed by the Commis-
sioner not later than 90 days after the date of enactment 
of this section. 
VerDate Mar 15 2010 
02:37 Dec 04, 2012
Jkt 029200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6201
E:\BILLS\H6626.IH
H6626
pwalker on DSK7TPTVN1PROD with
‘‘(c) DUTIES.—The Director of the Office shall— 
‘‘(1) through public meetings and other forms 
of communication with individuals and entities that 
design, produce, disseminate, or have a prevailing in-
terest in wireless health technology, receive and ana-
lyze recommendations with respect to ways that ex-
isting regulations regarding wireless health tech-
nology might be made more reasonable and predict-
able, including ways that such regulations could be 
clarified and simplified; 
‘‘(2) coordinate with federal agencies, offices, 
institutes, and centers involved in the regulation of 
wireless health technology, including the Federal 
Communications Commission, the Office of the Na-
tional Coordinator for Health Information Tech-
nology, the Centers for Medicare & Medicaid Serv-
ices, the Agency for Healthcare Research and Qual-
ity, the National Institute of Standards and Tech-
nology, the Health Resources and Services Adminis-
tration, and the National Institutes of Health, re-
garding activities of such agencies, offices, institutes, 
and centers that can be improved so as to make 
such regulation more robust, predictable, and easily 
understood and navigated by individuals and entities 
VerDate Mar 15 2010 
02:37 Dec 04, 2012
Jkt 029200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6201
E:\BILLS\H6626.IH
H6626
pwalker on DSK7TPTVN1PROD with
that design, produce, disseminate, or have a pre-
vailing interest in wireless health technology; 
‘‘(3) provide information to individuals and en-
tities that design, produce, disseminate, or have a 
prevailing interest in wireless health technology on 
how to design, produce, or disseminate wireless 
health technology in accordance with existing law; 
and 
‘‘(4) publish and make available on the public 
Internet website of the Food and Drug Administra-
tion in a searchable format an annual report that— 
‘‘(A) explains how the Food and Drug Ad-
ministration implemented regulations regarding 
wireless health technology during the prior 
year; 
‘‘(B) analyzes the effectiveness of— 
‘‘(i) such regulations; and 
‘‘(ii) other wireless health-related ef-
forts by the Food and Drug Administra-
tion; and 
‘‘(C) provides specific recommendations on 
how the Food and Drug Administration should 
improve its practices with regard to wireless 
health technology (in a manner that ensures 
consistency within the Food and Drug Adminis-
VerDate Mar 15 2010 
02:37 Dec 04, 2012
Jkt 029200
PO 00000
Frm 00020
Fmt 6652
Sfmt 6201
E:\BILLS\H6626.IH
H6626
pwalker on DSK7TPTVN1PROD with
tration regarding the application of its regu-
latory approach without compromising patient 
safety or privacy) in order to— 
‘‘(i) remove barriers to innovations in 
such technology; and 
‘‘(ii) align such practices with the 
practices of other Federal agencies. 
‘‘(d) CONSULTATION WITH WORKING GROUP AND 
COMMISSIONS.—In carrying out the duties specified in 
subsection (c), the Director of the Office shall consult with 
any working group convened under section 618(b)(1) of 
the Food and Drug Administration Safety and Innovation 
Act, and may consult with any Federal commission. 
‘‘(e) DEFINITION
OF WIRELESS HEALTH TECH-
NOLOGY.—For purposes of this section, the term ‘wireless 
health technology’ has such meaning as specified by the 
Commissioner pursuant to regulation, but in no case shall 
include technology this is not regulated under the provi-
sions of this Act (other than this section). 
‘‘(f) AUTHORIZATION OF APPROPRIATIONS.—There 
is authorized to be appropriated to carry out this section 
$1,000,000 for each of fiscal years 2014 through 2018.’’. 
VerDate Mar 15 2010 
02:37 Dec 04, 2012
Jkt 029200
PO 00000
Frm 00021
Fmt 6652
Sfmt 6201
E:\BILLS\H6626.IH
H6626
pwalker on DSK7TPTVN1PROD with
SEC. 6. MOBILE HEALTH SOFTWARE APPLICATION TECH-
NOLOGY RESPONSIBILITIES OF THE HEALTH 
INFORMATION 
TECHNOLOGY 
RESEARCH 
CENTER. 
Section 3012 of the Public Health Service Act (42 
U.S.C. 300jj-32) is amended— 
(1) in subsection (b), by adding at the end the 
following new paragraph: 
‘‘(4) ENCOURAGEMENT
OF
DESIGN, PRODUC-
TION, AND
DISSEMINATION
OF
MOBILE
HEALTH 
SOFTWARE APPLICATION TECHNOLOGY.— 
‘‘(A) IN
GENERAL.—In addition to the 
purposes under paragraph (3), the Center 
shall— 
‘‘(i) establish an educational website 
repository and a response mechanism (such 
as a national telephone number) to provide 
timely responses to questions in order to 
make information available and provide di-
rect support to individuals and entities 
that design, produce, disseminate, or have 
a prevailing interest in mobile health soft-
ware application technology regarding the 
actions such individuals and entities must 
take in order to ensure that such tech-
VerDate Mar 15 2010 
02:37 Dec 04, 2012
Jkt 029200
PO 00000
Frm 00022
Fmt 6652
Sfmt 6201
E:\BILLS\H6626.IH
H6626
pwalker on DSK7TPTVN1PROD with
nology is designed, produced, and dissemi-
nated in accordance with Federal law; and 
‘‘(ii) publish and make available on 
the public Internet website of the Depart-
ment in a searchable format an annual re-
port that— 
‘‘(I) highlights and explains the 
laws and regulations that commonly 
impede efforts by individuals and enti-
ties to design, produce, or disseminate 
mobile health software application 
technology; and 
‘‘(II) discusses the work the Cen-
ter has completed in the past year 
with regard to mobile health software 
application technology, including ac-
complishments by the Center and 
challenges that may require more 
work or outside support in order for 
the Center to accomplish the objec-
tives outlined in this subparagraph. 
‘‘(B) DEFINITION
OF
MOBILE
HEALTH 
SOFTWARE
APPLICATION
TECHNOLOGY.—For 
purposes of subparagraph (A), the term ‘mobile 
VerDate Mar 15 2010 
02:37 Dec 04, 2012
Jkt 029200
PO 00000
Frm 00023
Fmt 6652
Sfmt 6201
E:\BILLS\H6626.IH
H6626
pwalker on DSK7TPTVN1PROD with
health software application technology’ means a 
software program that— 
‘‘(i) offers health-related services and 
runs on a mobile device; or 
‘‘(ii) enables health-related services 
through other portals associated with the 
use of a mobile device. 
‘‘(C) 
AUTHORIZATION
OF
APPROPRIA-
TIONS.—There is authorized to be appropriated 
to carry out this paragraph $500,000 for each 
of fiscal years 2014 through 2018.’’; and 
(2) in subsection (c)(8), by deleting ‘‘paragraph 
(3)’’ and inserting ‘‘paragraphs (3) and (4)’’. 
SEC. 7. WORKFORCE RETRAINING GRANTS. 
(a) IN GENERAL.—The National Coordinator for 
Health Information Technology may award to eligible en-
tities grants to be used for training health care workers 
in health information technology (in this section referred 
to as ‘‘HIT’’). 
(b) PERIOD OF GRANT.—The period of a grant under 
this section shall be 24 months. 
(c) ELIGIBLE ENTITIES.—In this section, ‘‘eligible 
entities’’ means entities that provide clinical health care 
services to individuals within the United States. 
VerDate Mar 15 2010 
02:37 Dec 04, 2012
Jkt 029200
PO 00000
Frm 00024
Fmt 6652
Sfmt 6201
E:\BILLS\H6626.IH
H6626
pwalker on DSK7TPTVN1PROD with
(d) JOB TRANSITION.—As a condition on receipt of 
a grant under this section, a grantee shall ensure that 
each employee whose HIT training is funded by that grant 
assumes expanded duties with the grantee, either in the 
form of a new employment position or revised duties with-
in such employee’s existing employment position, that re-
quires the use of HIT, not more than 1 year after the 
employee completes the training. 
(e) REPORTING.—Each grantee shall submit a report 
not later than 24 months after receipt of a grant to the 
National Coordinator for Health Information Technology 
including the following: 
(1) The number of employees who received 
training pursuant to the grant. 
(2) The HIT skills covered during such training 
or trainings. 
(3) Documentation that each trained employee 
commenced or will commence work in a new position 
that satisfies the condition set forth in subsection 
(d). 
(f) AUTHORIZATION
OF APPROPRIATIONS.—There 
are authorized to be appropriated to carry out this section 
$10,000,000 for each of fiscal years 2014 through 2018. 
Æ 
VerDate Mar 15 2010 
02:37 Dec 04, 2012
Jkt 029200
PO 00000
Frm 00025
Fmt 6652
Sfmt 6301
E:\BILLS\H6626.IH
H6626
pwalker on DSK7TPTVN1PROD with